Cargando…

Pyomyositis in Children

Primary pyomyositis in children is prevalent in the tropics and increasingly being recognised from temperate regions. Staphylococcus aureus remains the principle causative organism worldwide, while proportion of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is on rise. Com...

Descripción completa

Detalles Bibliográficos
Autor principal: Verma, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102239/
https://www.ncbi.nlm.nih.gov/pubmed/26879741
http://dx.doi.org/10.1007/s11908-016-0520-2
_version_ 1783511783584038912
author Verma, Sanjay
author_facet Verma, Sanjay
author_sort Verma, Sanjay
collection PubMed
description Primary pyomyositis in children is prevalent in the tropics and increasingly being recognised from temperate regions. Staphylococcus aureus remains the principle causative organism worldwide, while proportion of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is on rise. Commonly involved groups are around the pelvis and lower limbs. Clinical presentation depends on the stage of disease, most commonly a child presenting with limping with fever. Early diagnosis and management are crucial. The investigation of choice is MRI scan. Appropriate antibiotic treatment should be instituted at the earliest opportunity along with drainage. Majority of patients show excellent and complete recovery with no long-term complications once treatment is started early. A high level of awareness and suspicion of this condition is warranted from all paediatric clinicians.
format Online
Article
Text
id pubmed-7102239
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-71022392020-03-31 Pyomyositis in Children Verma, Sanjay Curr Infect Dis Rep Pediatric Infectious Diseases (I Brook, Section Editor) Primary pyomyositis in children is prevalent in the tropics and increasingly being recognised from temperate regions. Staphylococcus aureus remains the principle causative organism worldwide, while proportion of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is on rise. Commonly involved groups are around the pelvis and lower limbs. Clinical presentation depends on the stage of disease, most commonly a child presenting with limping with fever. Early diagnosis and management are crucial. The investigation of choice is MRI scan. Appropriate antibiotic treatment should be instituted at the earliest opportunity along with drainage. Majority of patients show excellent and complete recovery with no long-term complications once treatment is started early. A high level of awareness and suspicion of this condition is warranted from all paediatric clinicians. Springer US 2016-02-15 2016 /pmc/articles/PMC7102239/ /pubmed/26879741 http://dx.doi.org/10.1007/s11908-016-0520-2 Text en © Springer Science+Business Media New York 2016 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Pediatric Infectious Diseases (I Brook, Section Editor)
Verma, Sanjay
Pyomyositis in Children
title Pyomyositis in Children
title_full Pyomyositis in Children
title_fullStr Pyomyositis in Children
title_full_unstemmed Pyomyositis in Children
title_short Pyomyositis in Children
title_sort pyomyositis in children
topic Pediatric Infectious Diseases (I Brook, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102239/
https://www.ncbi.nlm.nih.gov/pubmed/26879741
http://dx.doi.org/10.1007/s11908-016-0520-2
work_keys_str_mv AT vermasanjay pyomyositisinchildren